Application of Quality Risk Management To Set Viable Environmental Monitoring Frequencies in Biotechnology Processing and Support Areas

References

1. 1.↵
   1. Booth Anne F

   1. Booth A. F

   . A Method for Validating a Controlled Environment. In: Booth Anne F . Sterilization of Medical Devices. CRC Press: Boca Raton, 1999, 465–478.
2. 2.↵
   1. Reich R.,
   2. Miller M.,
   3. Patterson H

   . Developing a viable environmental monitoring program for nonsterile pharmaceutical operations. Pharm. Technol. 2003, 92–100.
3. 3.↵
   1. Moldenhauer J

   1. Sandle T

   . Environmental Monitoring: A Practical Approach. In Environmental Monitoring: A Comprehensive Handbook; Moldenhauer J ., Ed.; PDA/DHI: River Grove, IL, 2012; Vol. 6, pp 29–54.

   OpenUrl
4. 4.↵
   1. Sandle T

   . Environmental monitoring risk assessment. Journal of GXP Compliance 2006, 10 (2), 54–73.

   OpenUrl
5. 5.↵
   1. Agalloco J.,
   2. Akers J

   . Risk analysis for aseptic processing: the Akers-Agalloco method. Pharm. Technol. 2005, 29 (11), 74–88.

   OpenUrl
6. 6.↵
   1. Cundell A. M.,
   2. Bean R.,
   3. Massimore L.,
   4. Maier C

   . Statistical analysis of environmental monitoring data: Does a worst case time for monitoring clean rooms exist? PDA J. Pharm. Sci. Technol. 1998, 52 (6), 326–330.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Jones R

   . Pharmaceutical manufacturing: how to understand the process and assess the risks to patient safety. Pharm. Eng. 2009, 29 (6).
8. 8.↵
   U.S. Food and Drug Administration. Pharmaceutical GMPs for the 21^st Century—A Risk Based Approach. Final Report, Rockville, MD, September 2004.
9. 9.↵
   International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH Harmonised Tripartite Guideline, Q10: Pharmaceutical Quality System, 2008.
10. 10.↵
    Euradlex. The Rules Governing Medicinal Products in the European Community, Annex 1; European Commission, 2009.
11. 11.↵
    1. Jackson S

    . Successfully implementing total quality management tools within healthcare: What are the key actions? Int. J. Health Care Qual. Assur. 2001, 14 (4), 157–163.

    OpenUrlCrossRef
12. 12.↵
    ICH. ICH Harmonised Tripartite Guideline, Q9: Quality Risk Management, Version 4, 2005.
13. 13.↵
    1. Tidswell E. C.,
    2. McGarvey B

    . Quantitative risk modeling in aseptic manufacture. PDA J. Pharm. Sci. Technol. 2006, 60 (5), 267–283.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Whyte W.,
    2. Eaton T

    . Microbiological contamination models for use in risk assessment during pharmaceutical production. Eur. J. Parent. Pharm. Sci. 2004, 9 (1), 11–15.

    OpenUrl
15. 15.↵
    1. Vesper J. L

    . Risk Assessment and Risk Management in the Pharmaceutical Industry: Clear and Simple; PDA: Bethesda, MD, and Davis Healthcare International Publishing, LLC: River Grove, IL, 2006.
16. 16.↵
    1. Claycamp H. G

    . Probability concepts in quality risk management. PDA J. Pharm. Sci. Technol. 2012, I (1) 78–89.

    OpenUrl
17. 17.↵
    ISO/IEC Guide 73: Risk Management—Vocabulary. Guidelines for Use in Standards; International Standards Organisation: Geneva, Switzerland, 2002.
18. 18.↵
    1. Kemppainen J. K

    . The critical incident technique and nursing care quality research. J. Adv. Nurs. 2000, 32 (5), 1264–1271.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Sandle T

    . Current Perspectives in Environmental Monitoring—Pharmig Review No. 1; Pharmig: Stanstead Abbots, UK, 2010.
20. 20.↵
    PDA Technical Report No. 13 (Revised). Fundamentals of an Environmental Monitoring Program; PDA: Bethesda, MD, 2001.
21. 21.↵
    1. Jahnke M

    . Use of the HACCP concept for the risk analysis of pharmaceutical manufacturing processes. Eur. J. Parent. Sci. 1997, 2 (4) 113–117.

    OpenUrl
22. 22.↵
    1. Munro M. J.,
    2. Millar B. W.,
    3. Radley A. S

    . A risk assessment of the preparation of parenteral medicines in clinical areas. Hospital Pharmacist 2003, 10 (7), 303–305.

    OpenUrl
23. 23.↵
    1. Saghee M. R.,
    2. Sandle T.,
    3. Tidswell E. C

    1. Sandle T

    . Environmental Monitoring. In Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices; Saghee M. R., Sandle T., Tidswell E. C ., Eds.; Business Horizons: New Delhi, India, 2011; pp 293–326.
24. 24.↵
    1. Tran N. L.,
    2. Hasselbalch B.,
    3. Morgan K.,
    4. Claycamp G

    . “Elicitation of Expert Knowledge About Risks Associated with Pharmaceutical Manufacturing Process.” Pharmaceutical Engineering, July/August 2005: 24–38.